Dr. Graeme Ladds | Director of Pharmacovigilance & Chief Executive Officer

Dr. Graeme Ladds, Director of Pharmacovigilance & Chief Executive Officer, PharSafer

With a first degree in Biochemistry & Pharmacology and a PhD focussing on drug metabolism and Pharmacokinetics Graeme has worked in the areas of Drug Safety and Medical services for over 30 years.

Graeme has been working as Head of Global Pharmacovigilance and EU QP PV for many top 10 Pharma Companies (and small) Pharma, and has been CEO for the last 19 years for PharSafer®. Graeme is also a member of the DIA; TOPRA; RQA and the Institute of Directors and PIPA and has helped small start-up Companies (Biotech; Medical Devices; Biologics; Generics; Herbal; OTC) in their planning, growth and been involved in Company and product acquisitions, due diligence activities for product in-licensing and marketing and development strategies with partner and distributor Companies. Graeme has been involved in many drug development programmes, taking products from the bench to market in a wide range of therapeutic areas. Graeme also has an additional role as Research & Development Director for products to be developed for global launches.


World Drug Safety Congress Americas 2022 Day 1 @ 11:40

Case processing – the most important part of pharmacovigilance?

last published: 01/Oct/22 14:05 GMT

back to speakers

Get Involved At Drug Safety Congress Americas


To Sponsor Or Exhibit

Semen Sen
t/ +1 646 619 1793



To Speak

Gina McHugh
t/ +1 646 619 1775



Marketing & Press Opportunities

Taylor Post
t/ +1 646 619 1785